Viemed Healthcare, Inc. (VMD)

US — Healthcare Sector

Peers: PROF SIBN IRIX SRDX TBIO RCEL CLPT SGHT TMCI FNA VREX KIDS OFIX NPCE CVRX PRCT LUNG

Automate Your Wheel Strategy on VMD

With Tiblio's Option Bot, you can configure your own wheel strategy including VMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol VMD
Rev/Share 5.9044
Book/Share 3.1227
PB 1.9574
Debt/Equity 0.0502
CurrentRatio 1.3842
ROIC 0.1432

MktCap 264414155.0
FreeCF/Share -0.1644
PFCF -40.8047
PE 21.467
Debt/Assets 0.0524
DivYield 0
ROE 0.0963

Rating A-
Score 4
Recommendation Buy
P/E Score 2
DCF Score 4
P/B Score 3
D/E Score 3

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
No ratings available.

News

Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

VMD
Published: May 06, 2025 by: GlobeNewsWire
Sentiment: Neutral

LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment (“Lehan”), a healthcare company offering home medical equipment with specialties in respiratory care and women's health.

image for news Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

Viemed Healthcare: Remaining Bullish Due To Strong Forward-Looking EPS Revisions

VMD
Published: April 20, 2025 by: Seeking Alpha
Sentiment: Positive

Viemed Healthcare's stock has declined recently, but bullish EPS revisions and strong growth projections make it an attractive buy near its long-term bottom. The company projects significant revenue and EBITDA growth for 2025, with EPS expected to rise by 42.86% in 2025 and 52.5% in 2026. Viemed's valuation remains attractive, with positive cash flow and rising equity, despite the stock's recent bearish trend.

image for news Viemed Healthcare: Remaining Bullish Due To Strong Forward-Looking EPS Revisions

About Viemed Healthcare, Inc. (VMD)

IPO Date 2019-08-09
Website https://www.viemed.com
Industry Medical - Devices
CEO Casey Hoyt
Employees 1222

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.